Tessa Therapeutics Doses First Patient in Phase 1b Clinical Trial Investigating TT11…
Phase 1b clinical trial (ACTION) designed to evaluate TT11 as a potential second-line therapy TT11, Tessa’s autologous CD30-CAR-T therapy, is also being investigated as a monotherapy in…